rash at injection site semaglutide Reacciones en el sitio de inyección de GLP-1 y cómo evitarlas Semaglutide-Induced Atypical Pustular Drug Eruption:

Semaglutide produces greater weight loss and may improve insulin resistance more effectively, but cannot be used during pregnancy or conception planning

Myostatin inhibitorscomprising direct agents such as monoclonal antibodies and small molecules, as well as indirect modulators including follistatin-based strategies and other pathway regulatorshave demonstrated encouraging results in preclinical and early clinical studies by increasing muscle mass and improving muscle function

Arginase-1, predominantly expressed in macrophages, and arginase-2, localized in various cells including myofibroblasts, both contribute to proline generation

5.5 Acute Adrenal Insufficiency in Patients with Acquired HO In a clinical trial of adults and pediatric patients aged 4 years and older with acquired HO and secondary adrenal insufficiency, serious adverse reactions related to acute adrenal insufficiency were reported by 5% of IMCIVREE-treated patients and no placebo-treated patients